Is a nightly dose of 100 mg trazodone safe for an 83‑year‑old woman with insomnia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Trazodone 100 mg for Sleep in an 83-Year-Old Woman: Safety Concerns

No, 100 mg of trazodone is not recommended for sleep in an 83-year-old woman, and you should consider alternative FDA-approved hypnotics instead. The American Academy of Sleep Medicine explicitly recommends against using trazodone for insomnia treatment 1, and this dose carries significant safety risks in elderly patients.

Why Trazodone Is Not Recommended

Guideline Position

The 2017 AASM clinical practice guideline specifically states: "We suggest that clinicians not use trazodone as a treatment for sleep onset or sleep maintenance insomnia (versus no treatment) in adults" 1. This recommendation was based on trials using 50 mg doses—your patient would be receiving double this amount.

Age-Specific Safety Concerns in the Elderly

The FDA label and geriatric guidelines highlight multiple serious risks that are amplified in an 83-year-old woman 2:

Orthostatic Hypotension and Falls:

  • Hypotension and syncope are well-documented with trazodone 2
  • Falls were the most frequent adverse event (30% of participants) in a 2024 real-world study of older persons in long-term care 3
  • Elderly patients are at substantially higher risk for orthostatic hypotension 4
  • A fall at age 83 can be catastrophic—hip fractures carry 20-30% one-year mortality

Hyponatremia:

  • Elderly patients are at greater risk for SIADH and hyponatremia with trazodone 2
  • Can present as confusion, falls, seizures, or even coma
  • Serum sodium levels below 110 mmol/L have been reported 2

Cognitive Impairment:

  • Trazodone causes somnolence and sedation that impairs mental and physical abilities 2
  • In an 83-year-old, this increases delirium risk and further compounds fall risk

Bleeding Risk:

  • As a serotonergic agent, trazodone increases bleeding risk 2
  • If your patient takes aspirin, NSAIDs, or anticoagulants (common in this age group), the risk multiplies

What You Should Do Instead

First-Line Alternatives (AASM-Recommended)

The AASM guideline suggests these FDA-approved options for elderly patients 1:

For sleep onset insomnia:

  • Ramelteon 8 mg (melatonin agonist—safest profile in elderly)
  • Zaleplon 5 mg (start at half the standard 10 mg dose in elderly)

For sleep maintenance insomnia:

  • Doxepin 3-6 mg (specifically studied and effective in elderly)
  • Low-dose eszopiclone 1-2 mg (start low in elderly)

Key advantage: These agents have evidence-based efficacy and FDA approval for insomnia, unlike trazodone.

Non-Pharmacologic Approaches (Essential First Step)

The 2009 geriatric sleep guideline emphasizes cognitive-behavioral therapy for insomnia (CBT-I) and sleep hygiene 4:

  • Fixed wake time regardless of sleep obtained
  • Limit daytime napping to 30 minutes before 2 PM
  • Avoid caffeine, nicotine, alcohol
  • Use bedroom only for sleep
  • If unable to sleep after 20 minutes, leave bedroom and return when sleepy

If Trazodone Is Already Prescribed

Do not abruptly discontinue 2. Taper gradually to avoid withdrawal syndrome (anxiety, agitation, insomnia rebound, dizziness).

The Evidence Nuance

While recent meta-analyses show trazodone can improve subjective sleep quality and reduce nocturnal awakenings 5, 6, these benefits come with significant adverse effects. A 2024 meta-analysis found trazodone increased dropouts due to adverse effects (RR = 2.30) and was associated with more adverse effects overall 6.

Critically: Most trazodone studies used 50 mg doses 1, 5. At 100 mg in an 83-year-old, you're doubling the studied dose in a high-risk population. A 2026 study in myasthenia gravis patients used 25-100 mg and still reported hypotension, dizziness, and nausea 7.

Clinical Pitfalls to Avoid

  1. Don't assume "it's commonly used" means "it's evidence-based"—trazodone is popular off-label but lacks FDA approval for insomnia
  2. Don't ignore polypharmacy—check for drug interactions with antihypertensives (potentiates hypotension), anticoagulants (bleeding risk), and other serotonergic agents 2
  3. Don't forget to screen for depression—if present, trazodone at antidepressant doses (150-300 mg) might be appropriate, but 100 mg is subtherapeutic for depression and excessive for sleep 8
  4. Monitor sodium levels if you must use trazodone in elderly patients 2

The bottom line: At age 83, the risk-benefit ratio strongly favors FDA-approved hypnotics with better safety profiles over trazodone 100 mg for insomnia 1, 4, 2.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.